Clinical trial
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
NCT00044824 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00044824 |
|---|---|
| Title | Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma |
| Official title | A Multicenter, Double-Blind, Randomized, Parallel Groups Placebo-Controlled Study to Assess the Efficacy and Safety of Fexofenadine 120mg BID in Subjects With Mild to Moderate Persistent Asthma |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Fexofenadine |
| Enrollment | 1,000 |
| Start date | Feb 1, 2002 |
| Primary completion | Oct 1, 2003 |
| Completion | Oct 1, 2003 |
| First posted | Sep 17, 2002 |
| Last update posted | Aug 21, 2008 |
| Countries | Costa Rica, Guatemala, Hungary, Mexico, Poland, Russia, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: